UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 31, 2006
Commission File No. 0-11178
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
UTAH | 87-0342734 |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
Effective May 31, 2006, Utah Medical Products, Inc. modified its unsecured line-of-credit with U.S. Bank to extend the maturity date of the note by two years to May 31, 2008. All other terms of the note remain the same.
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | UTAH MEDICAL PRODUCTS, INC. |
| | REGISTRANT |
| | | |
| | | |
Date: 6/2/2006 | By: | /s/ Kevin L. Cornwell |
| | | Kevin L. Cornwell |
| | | CEO |
EXHIBIT INDEX
Index Number | Description |
| | |
| 10.1 | Fourth Amendment to Loan Agreement, dated May 31, 2006 between Utah Medical Products, Inc. and U.S. Bank National Association |
